- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Large National Study Identifies Mastectomy Trend in Early Stage Disease
The retrospective study, published in JAMA Surgery, could not necessarily point to the underlying reason for this treatment choice.
patients eligible for breast conservation surgery (BCS) are opting for mastectomy, breast reconstruction, and bilateral mastectomy in increasing numbers, US researchers have shown in one of the largest studies on the topic to date.
Confirming the results of several recent investigations, they found that the greatest increases in mastectomy rates during the past 2 decades were seen in women with node-negative and in situ tumors.
JAMA Surgery.
The study was published online on November 19 in
Medscape Medical News.
"I do think it's important for patients and providers to be aware of this," lead researcher Kristy L. Kummerow, MD, of Vanderbilt University Medical Center, Nashville, Tennessee, told
Link to the complete article on Medscape: http://bit.ly/1yYhzQz
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
